25 C
Vientiane
Tuesday, May 6, 2025
spot_img

Cision PR Newswire

Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial

BEIJING, May 6, 2025 /PRNewswire/ -- Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited (1177.HK), has achieved a milestone in developing its first-in-class analgesic drug (research code: TRD205), a highly selective angiotensin II type 2 receptor (AT2R) antagonist, with the first patient successfully dosed. As the first...

2025 Sunhak Peace Prize: Honoring Global Leaders in Peace innovation

SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- The Sunhak Peace Prize Committee, chaired by José Manuel Barroso, former President of the European Commission, proudly...

BLUETTI Unveils New Energy Innovations and Brand Identity at CES 2025

LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- BLUETTI, a trailblazer in clean energy technology, unveiled three new product series—Apex, Elite, and EnergyPro—during its Breaking the...

Alcott Global Announces 2025 Leaders in Supply Chain Awards Call for Nominations

Celebrating exceptional leadership in the global supply chain industry SINGAPORE, Jan. 15, 2025 /PRNewswire/ -- Alcott Global proudly announces the launch of the 2025 edition...

HIXXHOME Smart Birdfeeder and CoolFly App recognized as a House Digest Best of CES 2025

LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- A new smart birdfeeder from HIXXHOME and its companion app from CoolFly have been recognized by Home Digest...

Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference

- The company to mark new phase of growth at Bio Campus II with the opening of Plant 5 in April - Samsung Biologics to...

QNET’s BELITE 123: Your Trusted Partner in Sustainable Health and Weight Management

HONG KONG, Jan. 15, 2025 /PRNewswire/ -- With the start of a new year, many of us set ambitious goals to improve our health...